Lopinavir (ABT-378) is an antiretroviral of the protease inhibitor class. It is used
against HIV infections as a fixed-dose combination with another protease ...
The combination of lopinavir and ritonavir is used with other medications to treat
human immunodeficiency virus (HIV) infection. Lopinavir and ritonavir are in a ...
Easy to read patient leaflet for lopinavir/ritonavir. Includes indications, proper use,
special instructions, precautions, and possible side effects.
KALETRA<sup>®</sup> (lopinavir/ritonavir) is a prescription HIV-1 medicine that is used with
other HIV medicines to treat HIV-1 (Human Immunodeficiency Virus) infection in ...
KALETRA (lopinavir/ritonavir) is a co-formulation of lopinavir and ritonavir.
Lopinavir is an inhibitor of the HIV-1 protease. As co-formulated in KALETRA,
The amount of Lopinavir in the blood stream stays much higher if it is taken with a
small amount of ritonavir, another protease inhibitor. See Fact Sheet 442 for ...
Medscape - HIV dosing for Kaletra (lopinavir/ritonavir), frequency-based adverse
effects, comprehensive interactions, contraindications, pregnancy & lactation ...
Lopinavir and ritonavir combination is used in the treatment of the infection
caused by the human immunodeficiency virus (HIV). HIV is the virus responsible
Lopinavir/ritonavir (Kaletra, Aluvia) is a protease inhibitor drug available in tablet
and solution form. Lopinavir is marketed only with a boosting dose of ritonavir; ...
Aug 29, 2007 ... Description. Lopinavir (ABT-378) is an antiretroviral of the protease inhibitor class
. It is marketed by Abbott as Kaletra, a co-formulation with a ...